Nothing Special   »   [go: up one dir, main page]

Nagasawa et al., 1977 - Google Patents

Studies of the influence of N-substitution in heparin on its anticoagulant activity

Nagasawa et al., 1977

View PDF
Document ID
4517805933515859714
Author
Nagasawa K
Tokuyasu T
Inoue Y
Publication year
Publication venue
The Journal of Biochemistry

External Links

Snippet

Five partially N-desulfated heparin preparations (N-sulfate: 0.73–0.48 mol, O-sulfate: 1.33– 1.29 mol, anticoagulant activity: 134–102 USP units) were prepared by solvolytic N- desulfation of the pyridinium salt of hog mucosal heparin (N-sulfate: 0.83 mol, O-sulfate: 1.42 …
Continue reading at www.jstage.jst.go.jp (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0045—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Galacturonans, e.g. methyl ester of (alpha-1,4)-linked D-galacturonic acid units, i.e. pectin, or hydrolysis product of methyl ester of alpha-1,4-linked D-galacturonic acid units, i.e. pectinic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate

Similar Documents

Publication Publication Date Title
CA1171375A (en) Oligosaccharides having selective anticoagulation activity
Cifonelli Reaction of heparitin sulfate with nitrous acid
EP0789777B1 (en) Polysaccharides having a high iduronic acid content
Cifonelli The relationship of molecular weight, and sulfate content and distribution to anticoagulant activity of heparin preparations
Fransson et al. Structure of Dermatan Sulfate: VII. THE COPOLYMERIC STRUCTURE OF DERMATAN SULFATE FROM HORSE AORTA
Choi et al. The structure of keratan sulphates from various sources
Linker et al. Structural studies of heparitin sulfates
Yan et al. Molecular size is important for the safety and selective inhibition of intrinsic factor Xase for fucosylated chondroitin sulfate
CZ279081B6 (en) N,o-sulfated heparosanes, process of their preparation and pharmaceutical compositions containing said n,o-sulfated heparosanes and a strain escherichia coli (k5) sebr 3282
CA2285383C (en) Glycosaminoglycans having high antithrombotic activity
RU2361881C2 (en) Derivatives of polysaccharides with high thromobitic activity in plasma
Razi et al. Structural and functional properties of heparin analogues obtained by chemical sulphation of Escherichia coli K5 capsular polysaccharide
AU2002236118B2 (en) Highly sulfated derivatives of K5 polysaccharide and their preparation
US20080207895A1 (en) Methods for synthesizing polysaccharides
Nagasawa et al. Studies of the influence of N-substitution in heparin on its anticoagulant activity
US8513407B2 (en) Process for the preparation of N-acyl-(epi)K5-amine-O-sulfate-derivatives and products thus obtained
AU740671B2 (en) Oligosaccharide mixtures having antithrombotic activity
Linhardt et al. New methodologies in heparin structure analysis and the generation of LMW heparins
US20050256079A1 (en) Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained
Delaney et al. Changes in disaccharide composition of heparan sulphate fractions with increasing degrees of sulphation
Cifonelli Acid hydrolysis of acidic mucopolysaccharides
Watt et al. Comparison of ovine, bovine and porcine mucosal heparins and low molecular weight heparins by disaccharide analyses and 13C NMR
JP3522775B2 (en) Heparin unsaturated tetrasaccharide and method for producing the same
Kosakai et al. Study on the factors yielding high color in the carbazole reaction with hexuronic acid-containing substances
Kosakai et al. Stability of ester sulfates in heparin to solvolysis and dilute acid treatment